Tesaro, Inc.
🏢 View company profile →18Patents
16Active
18Granted
49Portfolio score
Filing activity: Nov 1, 2017 → Jul 15, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11155624B2 | Antibodies directed against programmed death-1 (PD-1) | Chemistry; Metallurgy | 2 | Active |
| US11622961B2 | Combination therapies for treating cancer | Human Necessities | 1 | Active |
| US11407830B2 | Methods of treating cancer with anti-PD-1 antibodies | Chemistry; Metallurgy | 1 | Active |
| US11091459B2 | Niraparib compositions | Chemistry; Metallurgy | 1 | Active |
| US11661453B2 | Combination therapies for treating cancer with niraparib and PD-1 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11926665B2 | Methods of treating cancer with anti-TIM-3 antibodies | Chemistry; Metallurgy | 1 | Active |
| US11161834B2 | Methods of manufacturing of niraparib | Emerging Cross-Sectional Technologies | 1 | Active |
| US11753472B2 | Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3) | Emerging Cross-Sectional Technologies | 1 | Active |
| US12297184B2 | Niraparib salts | Chemistry; Metallurgy | 0 | Active |
| US12005057B2 | Methods of treating ovarian cancer | General | 0 | Revoked |
| US11673877B2 | Niraparib compositions | Chemistry; Metallurgy | 0 | Active |
| US10829476B2 | Niraparib compositions | General | 0 | Revoked |
| US11801240B2 | Combination therapies and uses thereof | Human Necessities | 0 | Active |
| US11629137B2 | Methods of manufacturing of niraparib | Emerging Cross-Sectional Technologies | 0 | Active |
| US11730725B2 | Niraparib formulations | Human Necessities | 0 | Active |
| US12415855B2 | Methods of treating cancer with anti-PD-1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12156872B2 | Combination therapies for treating cancer | Electricity | 0 | Active |
| US12383542B2 | Methods of treating ovarian cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.